Organization · Venture Capital
ALIVE Israel HealthTech Fund
ALIVE Israel HealthTech Fund is a mid-to-late stage venture capital fund based in Savyon, Israel, focusing on HealthTech investments. It targets startups in Series A and B, aiming to enhance healthcare delivery through scalable technologies.
Overview
What ALIVE Israel HealthTech Fund does
What ALIVE Israel HealthTech Fund is
ALIVE Israel HealthTech Fund is a mid-to-late stage venture capital fund based in Savyon, Israel, focusing on HealthTech investments. It targets startups in Series A and B, aiming to enhance healthcare delivery through scalable technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find ALIVE Israel HealthTech Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
ALIVE Israel HealthTech Fund as a funder
Investment thesis
ALIVE Israel HealthTech Fund focuses on mid-to-late stage investments in HealthTech to optimize value creation through strategic partnerships and expertise in clinical and regulatory processes.
Focus narrative
ALIVE invests in mid-to-late stage companies that are developing innovative platform technologies across various sectors, including medical devices, diagnostics, digital health, healthcare IT, and artificial intelligence. The fund seeks companies with strong management teams, robust intellectual property, and a proven execution track record, positioned to leverage the strategic synergies offered by the ALIVE ecosystem.
Value beyond capital
ALIVE provides significant value to its portfolio companies through access to a robust clinical network, regulatory expertise, and commercial introductions via partnerships with HMOs and hospitals. The fund's strategic ecosystem enhances the growth potential of its investments, facilitating faster market adoption and scaling.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Series A · Series B · Series C · Growth Equity
- Regions
- Global · North America · Europe · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
- Recorded notable exits
- Innovalve and Cynerio
Portfolio context
Notable portfolio companies include: Medisafe: A digital therapeutics company providing medication management solutions. Innovalve: Develops an artificial mitral valve for heart disease treatment; acquired by Edwards Lifesciences. Cynerio: Offers a Healthcare IoT Platform for cybersecurity and asset management; acquired by Axonius. Beyeonics Vision: Develops AR vision and navigation solutions for ophthalmic surgeries. OncoHost: Utilizes Proteomics AI technology for personalized cancer treatment strategies. Vessi Medical: Develops a cryo spray system for treating Non Muscle Invasive Bladder Cancer (NMIBC).
Common questions
What to know about ALIVE Israel HealthTech Fund
Upseed classifies ALIVE Israel HealthTech Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.